Market Value3,554,553,000
Total Holdings77
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OYST / Oyster Point Pharma Inc
US3723091043 / GenMark Diagnostics, Inc
AMRS / Amyris Inc
ARYBU / ARYA Sciences Acquisition Corp II
BAX / Baxter International Inc.
NARI / Inari Medical, Inc.
RPTX / Repare Therapeutics Inc.
928551AA8 / VIVUS, Inc. Bond
US62857M1053 / MyoKardia, Inc.
PHGE / BiomX Inc.
STAA / STAAR Surgical Company
ZBH / Zimmer Biomet Holdings, Inc.
SRPT / Sarepta Therapeutics, Inc.
TELA / TELA Bio, Inc.
BLU / Bellus Health Inc
TBIO / Telesis Bio, Inc.
LJPC / La Jolla Pharmaceutical Co.
MDXG / MiMedx Group, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
ODT / Odonate Therapeutics Inc
BIOR / Biora Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
FREQ / Frequency Therapeutics Inc
PHGE.WS / BiomX Inc. Warrants to purchase one-half of a share of
TMDX / TransMedics Group, Inc.
PRQR / ProQR Therapeutics N.V.
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
ADVM / Adverum Biotechnologies, Inc.
NEO / NeoGenomics, Inc.
AXNX / Axonics, Inc.
CERN / Cerner Corp.
PROF / Profound Medical Corp.
XGN / Exagen Inc.
INMD / InMode Ltd.
DMTK / DermTech, Inc.
JNJ / Johnson & Johnson
VINC / Vincerx Pharma, Inc.
FLGT / Fulgent Genetics, Inc.
PAYX / Paychex, Inc.
OSUR / OraSure Technologies, Inc.
BMY / Bristol-Myers Squibb Company
ABUS / Arbutus Biopharma Corporation
TWST / Twist Bioscience Corporation
PSNL / Personalis, Inc.
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
MOTS / Motus GI Holdings, Inc.
GBT / Global Blood Therapeutics Inc.
DRNA / Dicerna Pharmaceuticals Inc
FIXX / Homology Medicines, Inc.
NSTG / NanoString Technologies, Inc.
IMVT / Immunovant, Inc.
ISEE / IVERIC bio Inc
MGNX / MacroGenics, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
VCEL / Vericel Corporation
AGEN / Agenus Inc.
APYX / Apyx Medical Corporation
STOK / Stoke Therapeutics, Inc.
VRAY / ViewRay Inc.
CLSD / Clearside Biomedical, Inc.
TXG / 10x Genomics, Inc.
CSTL / Castle Biosciences, Inc.
CTMX / CytomX Therapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc
RNA / Avidity Biosciences, Inc.
AXSM / Axsome Therapeutics, Inc.
ARVN / Arvinas, Inc.
MASI / Masimo Corporation
QURE / uniQure N.V.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PTCT / PTC Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
NTRA / Natera, Inc.
PTGX / Protagonist Therapeutics, Inc.
RGNX / REGENXBIO Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
MIST / Milestone Pharmaceuticals Inc.
RLMD / Relmada Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.